老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

21.47
+0.74003.57%
盘后：21.770.3000+1.40%19:57 EDT
成交量：649.01万
成交额：1.34亿
市值：27.16亿
市盈率：-11.77
高：21.80
开：21.00
低：19.25
收：20.73
52周最高：35.72
52周最低：16.10
股本：1.27亿
流通股本：7,811.99万
量比：1.67
换手率：8.31%
股息：- -
股息率：- -
每股收益(TTM):-1.8245
每股收益(LYR):-1.5970
净资产收益率：14.10%
总资产收益率：5.13%
市净率：6.77
市盈率(LYR):-13.44

数据加载中...

总览公司新闻公告
2020/10/27

重要事件披露

8-K - Current report
2020/07/30

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/01

重要事件披露

8-K - Current report
2020/05/13

重要事件披露

8-K - Current report
2020/05/07

重要事件披露

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
2020/04/29

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/04/06

重要事件披露

Current report, item 5.02
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/09

重要事件披露

Current report, items 1.01 and 8.01
2020/01/07

重要事件披露

Current report, item 2.02
2020/01/07

重要事件披露

Current report, item 8.01
2019/11/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/10/07

重要事件披露

Current report, items 5.02 and 9.01
更多